Searched for
ORAL CONTRACEPTIVE
Research suggests oral contraceptives can impair fear-regulation in womenThe research focused on the impact of combined oral contraceptives (COCs), containing synthetic hormones like estrogen and progestin, on fe...- Use of hormonal birth control pills may increase breast cancer risk by 20-30%, says studyThe use of progestogen-only contraceptives has increased substantially in recent years.
- Lupin gets USFDA nod for generic oral contraceptive pillLupin has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Drosp...
- Lupin launches generic oral contraceptive tablets in USThe USFDA had earlier given approval to market a generic version of Janssen Pharmaceuticals, Inc.'s Ortho Tri-Cyclen tablets in the same st...
- Obese women using oral contraceptives at stroke risk, says studyRisk factors for CVT overlap some with those for venous thromboembolism (VTE) and include cancer and oral contraceptives.
- Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin today said it has received US health regulator's final approval to market Blisovi oral contraceptive tablets in different strengths i...
- Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
- Glenmark Pharma rallies over 3% on talks to sell oral contraceptive unit"Given complex manufacturing processes and high investments, the competition is low in the segment and typically attracts only a few player...
- Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
- Lupin gains on FDA approval for oral contraceptiveShares of Lupin gained momentum in weak market after it received US FDA approval for oral contraceptive tablets.
- Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
- Oral Contraceptives Booster to Lupin's US businessAs per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.
- Lupin gets US nod for 7th oral contraceptiveLupin said that it has received final approval from the US health regulator to sell its generic oral contraceptive Levonorgestrel and Ethin...
- Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...
- Lupin gets USFDA approval for oral contraceptive tablets KurveloDrug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
- Lupin eyes $150 mn from oral contraceptives in US by FY14Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
- Lupin gets USFDA nod for generic oral contraceptive tabletsLupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
- Lupin gains on USFDA nod; Goldman recommends 'Buy'Shares of drugmaker Lupin rose nearly 2 percent after it received the US regulatory approval on Tuesday to launch oral contraceptive
- AIF Capital to invest $40 mn in Famy CareAIF Capital, one of the largest Asia-based independent private equity firms, on Wednesday announced that AIF Capital Asia III, LP has inves...
Load More
